JPRN-UMIN000049267暂停Unknown
PHarmacological Audit study of Safety and Effectiveness in Real world (Phase R): Opioid for Dyspnea in Patients with Non-malignant Respiratory Diseases Study - PHarmacological Audit study of Safety and Effectiveness in Real world (Phase R): Opioid for Dyspnea in Patients with Non-malignant Respiratory Diseases Study
ational Hospital Organization Kinki-Chuso Chest Medical Center0 个研究点目标入组 200 人开始时间: 2022年10月19日最近更新:
适应症
试验速览
- 阶段
- Unknown
- 状态
- 暂停
- 发起方
- 入组人数
- 200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. Patients who are scheduled to undergo an intervention (e.g., chest drainage of pneumothorax or pleural effusion, introduction or withdrawal of noninvasive respiratory management techniques such as NPPV or HFNC) that could cause a change in dyspnea intensity within 2 days of enrollment 2. Patients on invasive ventilation 3. Patients with malignant tumors in the thoracic cavity
研究者
相似试验
已完成
不适用
PHarmacological Audit study of Safety and Effectiveness in Real world: Naldemedine for Opioid-Induced Constipation studyopioid-induced constipationJPRN-UMIN000031381ational Cancer Center200
进行中（未招募）
不适用
Safety and Efficacy Study of Daptomycin in Pediatric Participants (1 to 17 Years-old) With Skin and Skin Structure InfectionsEUCTR2015-002778-19-Outside-EU/EEACubist Pharmaceuticals, Inc.389
未知
不适用
A-L03-L088 Other specified local infections of skin and subcutaneous tissue-L02Other specified local infections of skin and subcutaneous tissueL02L03L088PER-006-13Cubist Pharmaceuticals, Inc,
招募中
2 期
A Phase II Study of FYU-981 in Hyperuricemic Pediatric Patients with or without GoutHyperuricemic pediatric patients with or without goutJPRN-jRCT2031220036Masahiko Fushimi30
尚未招募
1 期
A Study Assessing the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of K-3505 in Healthy Volunteers (PART II)Neurological - Other neurological disordersMigraineACTRN12624001026516KALLYOPE, Inc.12